References
- Armitage, P. & Berry, G. (1991). Statistical Methods in Medicinal Research. Oxford: Blackwell Scientific.
- Batsanov, A., Brook, G., Holling, D. & Kenwright, A. (2000). Pyrolysis reactions of nonafluorobipheny1-4-y1 prop-2-enyl ether: a remarkable rearrangement reaction of an intramolecular Diels—Alder product. Journal of the Chemical Society, Perkin Transactions I, 11, 1731–1734.
- Christensen, S. B. & Kharazmi, A. (2001). Bioactive Compounds from Natural Sources. London: Taylor & Francis.
- Fonteneau, N., Martin, P., Mondo, M., Ficheux, H. & Gesson, J. P. (2001). Synthesis of quinone and xanthone analogs of rhein. Tetrahedron, 57,9131–9135.
- Fotie, J., Nkengfack, A. E., Peter, M. G., Heydenreich, M. & Fomum, Z. T. (2003). Chemical constituents of the ethyl acetate extracts of the stem bark and fruits of Dichrostachys cinerea and of the roots of Parkia bicolor. Fitoterapia, in press.
- Gessler, M. C., Tanner, M., Chollet, J., Nkunya, M. H. H. & Heinrich, M. (1995). Tanzanian medicinal plants used traditionally for the treatment of malaria: in vivo antimalarial and in vitro cytotoxicity activities. Phytotherapy Research, 9, 504–508.
- Hatsuda, Y. & Kuyama, S. (1955). Metabolic pro-ducts of Aspergillus versicolor. IV. The antibiotic of versicolorin and some hydroxyxanthone. Nippon Nogeikagaku Kaish, 29, 14–20.
- Ignatushchenko, M. V., Winter, R. W., Baechinger, H. P., Hinrichs, D. J. & Riscoe, M. K. (1997). Xanthones as antimalarial agents; studies of a possible mode of action. FEBS Letters, 409, 67–73.
- Ignatuschenko, M. V., Winter, R. W. & Riscoe, M. K. (2000). Xanthones as antimalarial agents: stage specificity. American Journal of Tropical Medicine and Hygiene, 62, 77–81.
- Kelly, J. X., Winter, R., Peyton, D. H., Hinrichs, D. J. & Riscoe, M. (2002). Optimization of xanthone for anti-malarial activity: the 3,6-bis-(0-diethylaminoalkoxy-xanthone series. Antimicrobial Agents and Chemotherapy, 46, 144–150.
- Kurono, M., Yamakawa, H., Koshizaka, T., Suzuki, T., Kato, E., Iida, T., Ohishi, N. & Yagi, K. (1988). Dihydtvxyzanthone-containing Plant Extracts for Inhibition of Binding of 5-a-Dihydrotestosterones to Androgen Receptors. European Patent Application EP-88-110140. Munchen: European Patent Office.
- Okenu, D. M. N. (1999). An integrated approach for malaria in Africa. Malaria and Infectious Diseases in Africa, 10, 10–13.
- Nkengfack, A. E., Azebaze, G. A., Vardamides, J. C., Fomum, Z. T. & van Heerden, F. R. (2002a). A prenylated xanthone from Allanblackia floribunda. Phytochemistly, 60, 381–384.
- Nkengfack, A. E., Mkounga, P., Meyer, M., Fomum, Z. T. & Bodo. B. (2002b). Globulixanthones C, D and E: three prenylated xanthones with anti-microbial properties from the root bark of Symphonia globulifera. Phytochemistly, 61, 181–187.
- Peters, W., Portus, J. H. & Robinson, B. L. (1975). The chemotherapy of rodent malaria XXII. The value of drug-resistant strains of P. berghei in screening for blood schizontocidal activity. Annals of Tropical Medicine and Parasitology, 69, 155–171.
- Suzuki, O., Katsumata, Y., Oya, M., Chari, V. M., Vermes, B., Warger, H. & Hostettmann, K. (1981). Inhibition of type A and type B monoamine oxidases by naturally occurring xanthones. Planta Medica, 42, 17–21.
- Tona, L., Mesia, K., Ngimbi, N. P., Chrimwami, B., Okond'ahoka, Cimanga, K., de Bruyne, T., Apers, S., Hermans, N., Totte, J., Pieters, I. & Vlietinck, A. J. (2001). In-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruri. Annals of Tropical Medicine and Parasitology, 95, 47–50.
- Ungwitayatorn, J., Pickert, M. & Frahm, A. W. (1997). Quantitative structure—activity (QSAR) study of polyhydroxyxanthones. Pharnzaceutica Acta Helvetiae, 72, 23–29.
- Winter, R. W., Ignatushchenko, M., Ogundahunsi, O. A. T., Cornell, K. A., Oduola, A. M. J., Hinrichs, D. J. & Riscoe, M. K. (1997). Potentiation of an antimalarial oxidant drug. Antimicrobial Agents and Chemotherapy, 41, 1449–1454.